T-cell-engaging B7-H4/CD3 bispecific Fab-scFv antibody targeting human breast cancer

被引：0
|
作者：
Iizuka, Akira [1 ]
Ashizawa, Tadashi [1 ]
Ohshima, Keiichi [2 ]
Kusuhara, Masatoshi [3 ]
Yamaguchi, Ken [4 ]
Akiyama, Yasuto [1 ]
机构：
[1] Shizuoka Canc Ctr, Res Inst, Dept Immunother, Nagaizumi, Shizuoka, Japan
[2] Shizuoka Canc Ctr, Res Inst, Med Genet Div, Nagaizumi, Shizuoka, Japan
[3] Shizuoka Canc Ctr, Res Inst, Reg Resources Div, Nagaizumi, Shizuoka, Japan
[4] Shizuoka Canc Ctr, Nagaizumi, Shizuoka, Japan
来源：
CANCER SCIENCE | 2018年 / 109卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-1143
引用
收藏
页码：413 / 413
页数：1
相关论文
共 50 条
  • [21] A Novel Bispecific Antibody against Human CD3 and Ephrin Receptor A10 for Breast Cancer Therapy
    Taki, Shintaro
    Kamada, Haruhiko
    Inoue, Masaki
    Nagano, Kazuya
    Mukai, Yohei
    Higashisaka, Kazuma
    Yoshioka, Yasuo
    Tsutsumi, Yasuo
    Tsunoda, Shin-ichi
    PLOS ONE, 2015, 10 (12):
  • [22] Glofitamab, a Novel, Bivalent CD20-Targeting T-Cell-Engaging Bispecific Antibody, Induces Durable Complete Remissions in Relapsed or Refractory B-Cell Lymphoma: A Phase I Trial
    Hutchings, Martin
    Morschhauser, Franck
    Iacoboni, Gloria
    Carlo-Stella, Carmelo
    Offner, Fritz C.
    Sureda, Anna
    Salles, Gilles
    Martinez-Lopez, Joaquin
    Crump, Michael
    Thomas, Denise N.
    Morcos, Peter N.
    Ferlini, Cristiano
    Broeske, Ann-Marie E.
    Belousov, Anton
    Bacac, Marina
    Dimier, Natalie
    Carlile, David J.
    Lundberg, Linda
    Perez-Callejo, David
    Umana, Pablo
    Moore, Tom
    Weisser, Martin
    Dickinson, Michael J.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (18) : 1959 - +
  • [23] Metastatic colorectal cancer cells from patients previously treated with chemotherapy are sensitive to T-cell killing mediated by CEA/CD3-bispecific T-cell-engaging BiTE antibody
    T Osada
    D Hsu
    S Hammond
    A Hobeika
    G Devi
    T M Clay
    H K Lyerly
    M A Morse
    British Journal of Cancer, 2010, 102 : 124 - 133
  • [24] Development of a Bispecific Nanobody Targeting CD20 on B-Cell Lymphoma Cells and CD3 on T Cells
    Liu, Yanlong
    Ao, Kexin
    Bao, Fuxiang
    Cheng, Yi
    Hao, Yanxia
    Zhang, Huimin
    Fu, Shan
    Xu, Jiaqi
    Wu, Qiyao
    VACCINES, 2022, 10 (08)
  • [25] A B7-H3-Targeted CD28 Bispecific Antibody Enhances the Activity of Anti-PD-1 and CD3 T-cell Engager Immunotherapies
    Moore, Gregory L.
    Zeng, Veronica G.
    Diaz, Juan E.
    Bonzon, Christine
    Avery, Kendra N.
    Rashid, Rumana
    Qi, Jing
    Nam, Dong Hyun
    Jacinto, Jonathan
    Dragovich, Matthew A.
    Kim, Yoon Kyung
    Balcazar, Karen P.
    Bakhit, Charles G.
    Eivazi, Araz
    Nguyen, Hanh
    Muchhal, Umesh S.
    Szymkowski, David E.
    Desjarlais, John R.
    Hedvat, Michael
    MOLECULAR CANCER THERAPEUTICS, 2025, 24 (03) : 331 - 344
  • [26] T cell-dependent bispecific antibody anti-CD79b/CD3 as a potential therapy for B-cell malignancies
    Wang, Peiyin
    Hristopoulos, Maria
    Clark, Robyn
    Chen, Yvonne
    Ellerman, Diego
    Mathieu, Mary
    Spiess, Christoph
    Li, Jessica
    Chalouni, Cecile
    Sukumaran, Siddharth
    Stefanich, Eric
    Wallin, Jeffrey
    Li, Robert
    Zabka, Tanja
    Totpal, Klara
    Dennis, Mark
    Ebens, Allen
    Gould, Stephen
    Polson, Andrew
    Sun, Liping Laura
    CANCER RESEARCH, 2017, 77
  • [27] Metastatic colorectal cancer cells from patients previously treated with chemotherapy are sensitive to T-cell killing mediated by CEA/CD3-bispecific T-cell-engaging BiTE antibody
    Osada, T.
    Hsu, D.
    Hammond, S.
    Hobelka, A.
    Devi, G.
    Clay, T. M.
    Lyerly, H. K.
    Morse, M. A.
    BRITISH JOURNAL OF CANCER, 2010, 102 (01) : 124 - 133
  • [28] 食管鳞癌组织中B7-H4、CD3表达变化及意义
    王高燕
    朱振龙
    李子良
    王旭
    傅天
    孔令红
    山东医药, 2014, 54 (38) : 57 - 59
  • [29] Comparison of the Clinicopathologic Features and T-Cell Infiltration of B7-H3 and B7-H4 Expression in Triple-negative Breast Cancer Subtypes
    Kim, Nah Ihm
    Park, Min Ho
    Cho, NamKi
    Lee, Ji Shin
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2022, 30 (04) : 246 - 256
  • [30] Anti-LYPD1/CD3 T-Cell-Dependent Bispecific Antibody for the Treatment of Ovarian Cancer
    Lo, Amy A.
    Johnston, Jennifer
    Li, Ji
    Mandikian, Danielle
    Hristopoulos, Maria
    Clark, Robyn
    Nickles, Dorothee
    Liang, Wei-Ching
    Hotzel, Kathy
    Dunlap, Debra
    Thinh Pham
    Cai, Hao
    Ovacik, Meric
    Bravo-Perez, Daniel
    Mai, Elaine
    Slaga, Dionysos
    Ellerman, Diego
    Ziai, James
    Totpal, Klara
    Lee, Genee
    Boswell, C. Andrew
    Payandeh, Jian
    Wu, Yan
    Junttila, Teemu T.
    MOLECULAR CANCER THERAPEUTICS, 2021, 20 (04) : 716 - 725
12345